Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia
- PMID: 30815286
- PMCID: PMC6361328
- DOI: 10.1136/bmjgh-2018-001118
Diagnostics for Nipah virus: a zoonotic pathogen endemic to Southeast Asia
Abstract
Nipah virus (NiV) is an emerging pathogen that, unlike other priority pathogens identified by WHO, is endemic to Southeast Asia. It is most commonly transmitted through exposure to saliva or excrement from the Pteropus fruit bat, or direct contact with intermediate animal hosts, such as pigs. NiV infection causes severe febrile encephalitic disease and/or respiratory disease; treatment options are limited to supportive care. A number of in-house diagnostic assays for NiV using serological and nucleic acid amplification techniques have been developed for NiV and are used in laboratory settings, including some early multiplex panels for differentiation of NiV infection from other febrile diseases. However, given the often rural and remote nature of NiV outbreak settings, there remains a need for rapid diagnostic tests that can be implemented at the point of care. Additionally, more reliable assays for surveillance of communities and livestock will be vital to achieving a better understanding of the ecology of the fruit bat host and transmission risk to other intermediate hosts, enabling implementation of a 'One Health' approach to outbreak prevention and the management of this zoonotic disease. An improved understanding of NiV viral diversity and infection kinetics or dynamics will be central to the development of new diagnostics, and access to clinical specimens must be improved to enable effective validation and external quality assessments. Target product profiles for NiV diagnostics should be refined to take into account these outstanding needs.
Keywords: NiV; henipavirus; in vitro diagnostics; nipah virus; outbreaks.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Mapping Risk of Nipah Virus Transmission from Bats to Humans in Thailand.Ecohealth. 2022 Jun;19(2):175-189. doi: 10.1007/s10393-022-01588-6. Epub 2022 Jun 3. Ecohealth. 2022. PMID: 35657574 Free PMC article.
-
Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.PLoS One. 2018 Apr 30;13(4):e0194385. doi: 10.1371/journal.pone.0194385. eCollection 2018. PLoS One. 2018. PMID: 29708971 Free PMC article.
-
Two decades of one health surveillance of Nipah virus in Thailand.One Health Outlook. 2021 Jul 5;3(1):12. doi: 10.1186/s42522-021-00044-9. One Health Outlook. 2021. PMID: 34218820 Free PMC article.
-
Henipavirus zoonosis: outbreaks, animal hosts and potential new emergence.Front Microbiol. 2023 Jul 17;14:1167085. doi: 10.3389/fmicb.2023.1167085. eCollection 2023. Front Microbiol. 2023. PMID: 37529329 Free PMC article. Review.
-
Possible high risk of transmission of the Nipah virus in South and South East Asia: a review.Trop Med Health. 2023 Aug 10;51(1):44. doi: 10.1186/s41182-023-00535-7. Trop Med Health. 2023. PMID: 37559114 Free PMC article. Review.
Cited by
-
A short communication of Nipah virus outbreak in India: An urgent rising concern.Ann Med Surg (Lond). 2022 Sep 8;82:104599. doi: 10.1016/j.amsu.2022.104599. eCollection 2022 Oct. Ann Med Surg (Lond). 2022. PMID: 36268453 Free PMC article.
-
Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus.Open Vet J. 2023 Sep;13(9):1056-1070. doi: 10.5455/OVJ.2023.v13.i9.1. Epub 2023 Sep 30. Open Vet J. 2023. PMID: 37842102 Free PMC article. Review.
-
Standardization & validation of Truenat™ point-of-care test for rapid diagnosis of Nipah.Indian J Med Res. 2021 Apr;154(4):645-649. doi: 10.4103/ijmr.IJMR_4717_20. Indian J Med Res. 2021. PMID: 34854433 Free PMC article. No abstract available.
-
Langya virus outbreak: current challenges and lesson learned from previous henipavirus outbreaks in China, Australia, and Southeast Asia.Bull Natl Res Cent. 2023;47(1):87. doi: 10.1186/s42269-023-01064-3. Epub 2023 Jun 13. Bull Natl Res Cent. 2023. PMID: 37334163 Free PMC article. Review.
-
Immunogenicity and Neutralization of Recombinant Vaccine Candidates Expressing F and G Glycoproteins against Nipah Virus.Vaccines (Basel). 2024 Aug 31;12(9):999. doi: 10.3390/vaccines12090999. Vaccines (Basel). 2024. PMID: 39340029 Free PMC article.
References
-
- Sherrini BA, Chong TT. Nipah encephalitis—an update. Med J Malaysia 2014;69(Suppl A:1):03–11. - PubMed
-
- Centers for Disease Control and Prevention (CDC) Update: outbreak of Nipah virus—Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep 1999;48:335–7. - PubMed
-
- WHO , 2018. Nipah Virus (NiV) Infection. http://www.who.int/csr/disease/nipah/en/ (accessed 25 Feb 2018).
LinkOut - more resources
Full Text Sources